Meneses CJ, Briones VCG, Moreno SA, Amezola CMA, Anaya TFJ, Mújica HM, Díaz de LPM, Briones GJC

Language: Spanish
References: 9
Page: 63-66
PDF size: 53.64 Kb.

ABSTRACT

Background: Acute renal failure (ARF) is a condition associated to multiple surgical and medical problems during pregnancy and puerperium. During ARF glomerular filtration rates are diminished resulting in elevated levels of β2-microglobulin (β2M), a low molecular weight polypeptide that undergoes glomerular filtration and tubular resorption. Increases in serum levels of this molecule have been previously documented in patients with ARF preceding a fall in glomerular filtration and the arisal of serum creatinine.
Objective: To determine the levels of β2M in obstetric patients with severe pre-eclampsia and ARF.
Material and methods: Case series of 20 patients with severe preeclampsia complicated with ARF documented by a creatinine clearance rate ‹ 25 mL/min in the Intensive Care Unit (ICU). β2M was determined by an Enzyme Linked Fluorescent Assay ELFA (BioMeriéux-Mex, VIDAS) with a normal cut-off point between 0.81-2.19 mg/L. Statistical analyses was performed using descriptive and inferential analyses using Student t test, and the results expressed in mean, standard deviation SD accepting a significance for p ‹ 0.05.
Results: Levels of β2M and creatinine clearance are included in table 1. We stratified the results between recovered and deceased patients showed in table 2.
Conclusions: β2M and creatinine clearance rates are useful markers for ARF.
Discussion: There is statistical difference between in the levels of β2M between the deceased and surviving patients suggesting that a systemic inflammatory response is involved in the genesis of ARF in severe pre-ecliptic patients. Further studies are necessary to determine the true value of β2M in this patients.

REFERENCES

1. Briones GJC, Díaz de León PM, Gómez Bravo TE, Ávila EF, Salazar ED, Morales RG, Briones VCG, González LS. Insuficiencia renal aguda en la preeclampsia-eclampsia. Nefrología Mexicana 1999;20(2):69-72.

2. Briones GJC, Díaz de León PM, Meza VM, García RL, Villagrán UA, Cardona ChJG, Navarro ZJJ, Briones VCG. Disfunción renal en la preeclampsia-eclampsia. Nefrología Mexicana 1999;20(2):65-68.

3. Díaz de León PM, Briones GJC, Moreno SAA, González DJI. Patología renal en el embarazo. Nefrología Mexicana 2006;27(1):20-26.

4. Briones GJC, Díaz de León PM, Rodríguez RM, Briones VCG, Torres PJ. Diálisis peritoneal en pacientes obstétricas. Cir Ciruj 2006;74:15-20.

5. Schardijn GHS, Statius VE. B2 Microglobulin: Its significance in the evaluation of renal function. Kidney International 1987;32:635-641.

6. VIDAS b2 Microglobulin. REF 30 420. 07132H-FR-2004/09 bioMeréux sa Francais.

7. Miyata T, Jadoul M, Kurokawa K, Ypersele de Strihou ChV. Beta-2 microglobulin in renal disease. Journal of the American Society of Nephrology 1998;9(9):1723-35.

8. Reichert LJ, Koene RAP, Wetzels JFM. Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. Juornal of the American Society of Nephrology 1995;6(6):1666-9.

9. Haddad B, Desvaux D, Livingston JC, Barrenger E, Paniel BJ, Sibai BM. Failure of serum beta2-microglobulin levels as an early marker of preeclampsia. Am J Obstet Gynecol 2000;182(3):595-8.